These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31149766)

  • 1. Lower serum adiponectin level is associated with lipodystrophy among HIV-infected men in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN) study.
    Klos B; Patel P; Rose C; Bush T; Conley L; Kojic EM; Henry K; Brooks JT; Hammer J;
    HIV Med; 2019 Sep; 20(8):534-541. PubMed ID: 31149766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Glucose Tolerance and Metabolomic Profiles, Independent of Adiposity, in HIV-Infected Women Compared With Men on Antiretroviral Therapy.
    Koethe JR; Jenkins CA; Petucci C; Culver J; Shepherd BE; Sterling TR
    Medicine (Baltimore); 2016 May; 95(19):e3634. PubMed ID: 27175676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
    Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
    HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
    Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.
    Wangsomboonsiri W; Mahasirimongkol S; Chantarangsu S; Kiertiburanakul S; Charoenyingwattana A; Komindr S; Thongnak C; Mushiroda T; Nakamura Y; Chantratita W; Sungkanuparph S
    Clin Infect Dis; 2010 Feb; 50(4):597-604. PubMed ID: 20073992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal.
    Alikhani A; Morin H; Matte S; Alikhani P; Tremblay C; Durand M
    BMC Infect Dis; 2019 Sep; 19(1):820. PubMed ID: 31533648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body image is a major determinant of sexual dysfunction in stable HIV-infected women.
    Luzi K; Guaraldi G; Murri R; De Paola M; Orlando G; Squillace N; Esposito R; Rochira V; Zirilli L; Martinez E
    Antivir Ther; 2009; 14(1):85-92. PubMed ID: 19320240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
    Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.
    Freitas P; Carvalho D; Santos AC; Madureira AJ; Xerinda S; Martinez E; Pereira J; Sarmento A; Medina JL
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):593-600. PubMed ID: 22947357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection.
    Guaraldi G; Stentarelli C; Zona S; Santoro A; Beghetto B; Carli F; Orlando G; Franceschetto A; Casolo A; Mussini C
    HIV Med; 2014 Nov; 15(10):587-94. PubMed ID: 24750806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of metabolic syndrome in Ethiopia: describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study.
    Abdela AA; Yifter H; Reja A; Shewaamare A; Ofotokun I; Degu WA
    BMJ Open; 2023 Dec; 13(12):e069637. PubMed ID: 38070936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of adiponectin/leptin ratio with carbohydrate and lipid metabolism parameters in HIV-infected patients during antiretroviral therapy.
    Tiliscan C; Arama V; Mihailescu R; Munteanu D; Iacob DG; Popescu C; Catana R; Negru A; Lobodan A; Arama SS
    Endocr Res; 2018 Aug; 43(3):149-154. PubMed ID: 29451987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipodystrophy, insulin resistance, and adiponectin concentration in HIV-infected children and adolescents.
    Viganò A; Zuccotti GV; Cerini C; Stucchi S; Puzzovio M; Giacomet V; Mora S
    Curr HIV Res; 2011 Jul; 9(5):321-6. PubMed ID: 21827385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.
    Carter VM; Hoy JF; Bailey M; Colman PG; Nyulasi I; Mijch AM
    HIV Med; 2001 Jul; 2(3):174-80. PubMed ID: 11737398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.
    Heath KV; Hogg RS; Chan KJ; Harris M; Montessori V; O'Shaughnessy MV; Montanera JS
    AIDS; 2001 Jan; 15(2):231-9. PubMed ID: 11216932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.
    Egaña-Gorroño L; Martínez E; Pérez I; Escribà T; Domingo P; Gatell JM; Arnedo M
    J Antimicrob Chemother; 2014 Nov; 69(11):3076-84. PubMed ID: 25185137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.
    Kosmiski LA; Kuritzkes DR; Lichtenstein KA; Glueck DH; Gourley PJ; Stamm ER; Scherzinger AL; Eckel RH
    AIDS; 2001 Oct; 15(15):1993-2000. PubMed ID: 11600828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.